OR WAIT null SECS
June 02, 2009
Pharmacosomes can pass through biomembranes efficiently and possess several advantages over traditional vesicular drug-delivery systems.
Misleading the public about their investments-be it money or medicine-is unacceptable.
CROs and CMOs expand to gain a piece of the market for clinical trial materials.
Follow-on biologics could unleash the potential of several industries and may even spark economic recovery.
It can take a lot of work to make sure nothing happens.
June 01, 2009
The importance of liposomes as an effective drug delivery system is well accepted in the pharmaceutical industry, but their handling remains a challenge.
May 28, 2009
Also, Johnson & Johnson acquires Cougar Biotechnology; NIH launches program for rare and neglected diseases; PPD restructures leadership positions; more...
May 21, 2009
Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO; more...
May 14, 2009
Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president and CEO; more...
May 08, 2009
Covance talks about the risks, challenges, and tests required to develop a pandemic vaccine.